Marcus Soliai
About Marcus Soliai
Marcus Soliai is an Associate Statistical Geneticist at BridgeBio, specializing in respiratory diseases such as asthma. He has extensive experience in genetics and biotechnology, having worked in various research and analytical roles across multiple institutions.
Work at BridgeBio
Marcus Soliai has been employed at BridgeBio as an Associate Statistical Geneticist since 2020. In this role, he focuses on applying statistical methods to genetic data, contributing to the company's mission of advancing genetic medicine. His work involves integrating various types of genomic data to inform research and development efforts in the field of genetics.
Previous Experience in Forensic Biology
Prior to his current position, Marcus Soliai worked at the United States Department of Defense as a Forensic Biologist and DNA Analyst for 11 months in 2012. This role was based in the Greater Atlanta Area, where he applied his expertise in DNA analysis to support forensic investigations.
Education and Expertise
Marcus Soliai holds a Doctor of Philosophy (Ph.D.) in Genetics, Genomics, and Systems Biology from The University of Chicago, where he was a candidate from 2014 to 2020. He also earned a Master of Science (MS) and a Bachelor of Science (BS) in Genetics and Biotechnology from Brigham Young University. His educational background equips him with a strong foundation in genetic research and analysis.
Research Focus and Contributions
Marcus Soliai's research primarily focuses on respiratory diseases, particularly asthma. He integrates various genomic data types, including gene expression (RNA-seq), DNA methylation, and 3D chromatin conformation capture (Hi-C), to advance understanding in this area. His commitment to translational research reflects a passion for translating scientific discoveries into practical applications.
Leadership and Entrepreneurial Roles
In addition to his research roles, Marcus Soliai served as the co-chair of the UChicago Biotechnology Association Spark Grant Fellows. He also participated as an entrepreneurial lead of an NSF I-Corps team, showcasing his involvement in bridging the gap between scientific research and entrepreneurial ventures.